...
首页> 外文期刊>International journal of oncology >Effects of fucoidan on proliferation, AMP-activated protein kinase, and downstream metabolism- and cell cycle-associated molecules in poorly differentiated human hepatoma HLF cells
【24h】

Effects of fucoidan on proliferation, AMP-activated protein kinase, and downstream metabolism- and cell cycle-associated molecules in poorly differentiated human hepatoma HLF cells

机译:岩藻依聚糖对低分化人肝癌HLF细胞增殖,AMP活化蛋白激酶以及下游代谢和细胞周期相关分子的影响

获取原文
           

摘要

Survival rates are low in patients with poorly differentiated hepatocellular carcinoma (HCC). Fucoidan, a sulfated polysaccharide derived from brown seaweed, has anticancer activity; however, the effects of fucoidan on poorly differentiated HCC remain unclear. In this study, we investigated the effects of fucoidan on AMP-activated protein kinase (AMPK), a proliferation regulator, and its downstream metabolism- and cell cycle-related molecules in a poorly differentiated human hepatoma HLF cell line. HLF cells were treated with fucoidan (10, 50, or 100?μg/ml; n=4) or phosphate buffered saline (control; n=4) for 96?h. Proliferation was evaluated by counting cells every 24?h. AMPK, TSC2, mTOR, GSK3β, acetyl-CoA carboxylase (ACC), ATP-citrate lyase, p53, cyclin D1, cyclin-dependent kinase (CDK) 4, and CDK6 expression and/or phosphorylation were examined by immunoblotting 24?h after treatment with 100?μg/ml fucoidan. Cell cycle progression was analyzed by fluorescence-activated cell sorter 48?h after treatment. Treatment with 50 or 100?μg/ml fucoidan significantly and dose- and time-dependently suppressed HLF cell proliferation (P<0.0001). Fucoidan induced AMPK phosphorylation on Ser172 24?h after treatment. Although no differences were seen in expression and phosphorylation levels of TSC2, mTOR, GSK3β, ATP-citrate lyase, and p53 between the control and fucoidan-treated HLF cells, fucoidan induced ACC phosphorylation on Ser79. Moreover, fucoidan decreased cyclin D1, CDK4 and CDK6 expression 24?h after treatment. Furthermore, HLF cells were arrested in the G1/S?phase 48?h after fucoidan treatment. We demonstrated that fucoidan suppressed HLF cell proliferation with AMPK phosphorylation. We showed that fucoidan phosphorylated ACC and downregulated cyclin D1, CDK4 and CDK6 expression. Our findings suggest that fucoidan inhibits proliferation through AMPK-associated suppression of fatty acid synthesis and G1/S?transition in HLF cells.
机译:低分化肝细胞癌(HCC)患者的生存率很低。岩藻依聚糖是一种从褐藻中提取的硫酸化多糖,具有抗癌活性。然而,岩藻依聚糖对低分化肝癌的影响尚不清楚。在这项研究中,我们研究了岩藻依聚糖对低分化人肝癌HLF细胞系中AMP激活的蛋白激酶(AMPK),增殖调节剂及其下游代谢和细胞周期相关分子的影响。用岩藻依聚糖(10、50或100?μg/ ml; n = 4)或磷酸盐缓冲液(对照组; n = 4)处理HLF细胞96?h。通过每24小时对细胞计数来评估增殖。 AMPK,TSC2,mTOR,GSK3β,乙酰辅酶A羧化酶(ACC),柠檬酸ATP裂解酶,p53,细胞周期蛋白D1,细胞周期蛋白依赖性激酶(CDK)4和CDK6表达和/或磷酸化在24小时后进行了免疫印迹分析用100?μg/ ml岩藻依聚糖处理。处理后48小时,用荧光激活的细胞分选仪分析细胞周期进程。用50μg/ ml或100μg/ ml岩藻依聚糖处理可显着且剂量和时间依赖性地抑制HLF细胞增殖(P <0.0001)。处理后24小时,岩藻糖聚糖诱导Ser172上的AMPK磷酸化。尽管在对照和岩藻依聚糖处理的HLF细胞之间,TSC2,mTOR,GSK3β,ATP柠檬酸裂解酶和p53的表达和磷酸化水平均未见差异,但岩藻依聚糖诱导Ser79上的ACC磷酸化。此外,岩藻依聚糖在治疗后24小时降低了细胞周期蛋白D1,CDK4和CDK6的表达。此外,在岩藻依聚糖处理后48小时,HLF细胞被阻滞在G1 / S2期。我们证明了岩藻依聚糖通过AMPK磷酸化抑制HLF细胞增殖。我们表明岩藻依聚糖磷酸化ACC和下调细胞周期蛋白D1,CDK4和CDK6表达。我们的发现表明,岩藻依聚糖通过AMPK相关的HLF细胞中脂肪酸合成和G1 / S1过渡的抑制而抑制增殖。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号